SAN FRANCISCO (TheStreet) -- It's Day One of the 32nd annual J.P. Morgan Healthcare Conference. Welcome to TheStreet's live-blog coverage which today will include presentations from Celgene (CELG - Get Report), InterMune (ITMN), Gilead Sciences (GILD - Get Report) and Medivation (MDVN).
Here's how this live blog is going to (hopefully) work: I will be posting news updates and analysis throughout the day, live from the presentation rooms and breakout (Q&A) sessions. You can also follow me on Twitter, my handle is @adamfeuerstein.Your best bet is to check back into the live blog several times throughout the day. Feel free to ping me with questions and comments. I'll do my best to respond and keep the live blog as interactive as possible. Here's my planned schedule for Monday, subject to change, of course. All times Eastern. And yes, my schedule will change. The J.P. Morgan conference is crazy like that. Celgene 11 am
InterMune 12 pm
Biomarin (BMRN) 1:30 pm
Alnylam Pharma (ALN)Y 2:30 pm
Arena Pharma (ARNA - Get Report) 4:30 pm
Gilead Sciences 5:30 pm
Clovis Oncology (CLVS) 6:30 pm
Medivation 7:30 pm
Serious drinking 8 pm until ? -- Reported by Adam Feuerstein in San Francisco. Follow Adam Feuerstein on Twitter.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts